Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 4/20 | 0.65 |
| ▸ | ACACA | Q13085 | 4/20 | 0.65 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.61 |
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.58 |
| ▸ | LMNA | P02545 | 2/20 | 0.58 |
| ▸ | HPGD | P15428 | 1/20 | 0.58 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.56 |
| ▸ | RECQL | P46063 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | NPC1 | O15118 | 1/20 | 0.56 |
| ▸ | MMP9 | P14780 | 1/20 | 0.54 |
| ▸ | MMP8 | P22894 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1754100 | 1.00 | ACACB (0.65) | ACACBACACAHSD17B10MEN1KMT2A | |
| SCHEMBL640385 | 1.00 | ACACB (0.65) | ACACBACACAHSD17B10MEN1KMT2A | |
| SCHEMBL5043127 | 0.98 | ACACB (0.63) | ACACBACACAHSD17B10MEN1KMT2A | |
| SCHEMBL3861309 | 0.91 | ACACB (0.56) | ACACBACACAHSD17B10MEN1KMT2A | |
| SCHEMBL7736414 | 0.88 | ACACB (0.77) | ACACBACACAMEN1KMT2AALDH1A1 | |
| SCHEMBL25336459 | 0.84 | MMP9 (0.66) | HSD17B10MEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL247742 | 0.84 | HSD17B10 (0.63) | HSD17B10MEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL8715641 | 0.84 | HSD17B10 (0.75) | HSD17B10MEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL249524 | 0.84 | HSD17B10 (0.63) | HSD17B10MEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL2672977 | 0.84 | HSD17B10 (0.63) | HSD17B10MEN1KMT2AALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 263 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110403931-B | Medical application of 5-hydroxyflavone substituted N-phenethyl acetamide in resisting mycobacterium tuberculosis infection | 厦门大学 | 2022-08-23 | — | — | CN | claimed |
| CN-108299251-B | Preparation method of glimepiride impurity | 山东新华制药股份有限公司 | 2020-10-30 | — | — | CN | claimed |
| CN-110403930-A | Medical usage of 5- Sunkatol No. 1 substitution-N-3 ' the methylbenzyl acetamide in Killing Mycobacterium Tuberculosis infection | UNIV XIAMEN | 2019-11-05 | — | — | CN | claimed |
| CN-107567445-A | It can be used as 2 phenyl 3H imidazos [4,5 B] pyridine derivates of mammal EGFR-TK ROR1 activities inhibitor | 坎塞拉有限公司 | 2018-01-09 | — | — | CN | claimed |
| CN-104152525-B | A kind of method that fractionation prepares the phenyl ethylamines of optical voidness R 1 | 上海同昌生物医药科技有限公司 | 2017-09-29 | — | — | CN | claimed |
| CN-104152526-B | The method of optical voidness R-1-phenethylamine is prepared in a kind of fractionation | 六安佳诺生化科技有限公司 | 2016-12-07 | — | — | CN | claimed |
| CN-104131062-B | The method of optical voidness S-1-phenethylamine is prepared in a kind of fractionation | 陈永军 | 2016-11-23 | — | — | CN | claimed |
| CN-104151169-B | The method of optical voidness S-1-phenethylamine is prepared in a kind of fractionation | 六安佳诺生化科技有限公司 | 2016-08-24 | — | — | CN | claimed |
| CN-104152525-A | Resolution method for preparing optically pure R-1-phenylethylamine | CHEN YONGJUN | 2014-11-19 | — | — | CN | claimed |
| CN-104151169-A | Method for resolution preparation of optically pure S-1-phenylethylamine | CHEN YONGJUN | 2014-11-19 | — | — | CN | claimed |
| WO-1997041214-A1 | BIOCATALYSTS WITH AMINE ACYLASE ACTIVITY | NOVARTIS AG (CH) | 1997-11-06 | — | — | WO | claimed |
| EP-0594608-B1 | CHIRAL CATALYSTS FOR ENANTIOSELECTIVE SYNTHESIS | RES CORP TECHNOLOGIES INC (US) | 1997-10-15 | — | — | EP | claimed |
| EP-0594608-A1 | CHIRAL CATALYSTS FOR ENANTIOSELECTIVE SYNTHESIS. | RES CORP TECHNOLOGIES INC (US) | 1994-05-04 | — | — | EP | claimed |
| US-5296595-A | Metal complexes with bridging ligands | RESEARCH CORPORATION TECHNOLOGIES (US) | 1994-03-22 | — | — | US | claimed |
| EP-0594608-A4 | CHIRAL CATALYSTS FOR ENANTIOSELECTIVE SYNTHESIS. | RES CORP TECHNOLOGIES INC (US) | 1993-03-15 | — | — | EP | claimed |
| EP-0459983-A1 | ANTIATHEROSCLEROTIC AND ANTITHROMBOTIC 1-BENZOPYRAN-4-ONES AND 2-AMINO-1,3-BENZOXAZINE-4-ONES | PHARMACIA & UPJOHN COMPANY (US) | 1991-12-11 | — | — | EP | claimed |
| WO-1991014672-A1 | CHIRAL CATALYSTS FOR ENANTIOSELECTIVE SYNTHESIS | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1991-10-03 | — | — | WO | claimed |
| EP-0201039-B1 | L-AMINOACYLASES | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1991-07-31 | — | — | EP | claimed |
| WO-1990006921-A1 | ANTIATHEROSCLEROTIC AND ANTITHROMBOTIC 1-BENZOPYRAN-4-ONES AND 2-AMINO-1,3-BENZOXAZINE-4-ONES | THE UPJOHN COMPANY (US) | 1990-06-28 | — | — | WO | claimed |
| EP-0201039-A2 | L-aminoacylases | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1986-11-12 | — | — | EP | claimed |